Jeanine May

1.8k total citations
17 papers, 454 citations indexed

About

Jeanine May is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jeanine May has authored 17 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jeanine May's work include Influenza Virus Research Studies (5 papers), Adenosine and Purinergic Signaling (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Jeanine May is often cited by papers focused on Influenza Virus Research Studies (5 papers), Adenosine and Purinergic Signaling (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Jeanine May collaborates with scholars based in United States. Jeanine May's co-authors include Elizabeth M. Hofmeister, Ron D. Hays, Frederick L. Ferris, Gene Hilmantel, Michelle E. Tarver, Keri Hammel, J. D. Belluzzi, Donald A. McAfee, Krys S. Bankiewicz and E. F. Domino and has published in prestigious journals such as JAMA, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeanine May

17 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanine May United States 12 177 111 102 94 85 17 454
Ramji Singh India 11 35 0.2× 39 0.4× 49 0.5× 37 0.4× 23 0.3× 52 305
G Farnarier France 14 31 0.2× 57 0.5× 71 0.7× 9 0.1× 48 0.6× 60 544
Hiroaki Fujita Japan 15 175 1.0× 33 0.3× 188 1.8× 6 0.1× 39 0.5× 63 688
In Soo Kim South Korea 12 160 0.9× 21 0.2× 206 2.0× 16 0.2× 5 0.1× 23 627
Frederick W. Schaerf United States 9 103 0.6× 140 1.3× 89 0.9× 57 0.6× 30 0.4× 15 853
Takuya Tanabe Japan 18 158 0.9× 32 0.3× 95 0.9× 12 0.1× 66 0.8× 64 885
Allen L. Pelletier United States 7 56 0.3× 39 0.4× 14 0.1× 32 0.3× 64 0.8× 12 315
Stefano Valente Italy 9 79 0.4× 35 0.3× 54 0.5× 27 0.3× 9 0.1× 30 318
Susan Pross United States 19 78 0.4× 112 1.0× 148 1.5× 28 0.3× 110 1.3× 41 921
Frances W. Carnie United Kingdom 7 102 0.6× 56 0.5× 87 0.9× 8 0.1× 72 0.8× 7 647

Countries citing papers authored by Jeanine May

Since Specialization
Citations

This map shows the geographic impact of Jeanine May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanine May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanine May more than expected).

Fields of papers citing papers by Jeanine May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanine May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanine May. The network helps show where Jeanine May may publish in the future.

Co-authorship network of co-authors of Jeanine May

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanine May. A scholar is included among the top collaborators of Jeanine May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanine May. Jeanine May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Gorse, Geoffrey J., Hussain Mulla, Peter White, et al.. (2022). A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system. Vaccine. 40(9). 1271–1281. 9 indexed citations
4.
Williams, Mark S., Tína Guina, J. Hewitt, et al.. (2019). Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline Efficacy. Frontiers in Medicine. 6. 229–229. 13 indexed citations
5.
Houser, Katherine V., Galina V. Yamshchikov, Abbie R. Bellamy, et al.. (2018). DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. PLoS ONE. 13(11). e0206837–e0206837. 23 indexed citations
6.
Gorse, Geoffrey J., Hussain Mulla, Peter White, et al.. (2017). Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses. Open Forum Infectious Diseases. 4(suppl_1). S455–S455. 1 indexed citations
7.
Lee, Joshua D., Edward V. Nunes, Patricia Novo, et al.. (2016). NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale. Contemporary Clinical Trials. 50. 253–264. 49 indexed citations
8.
Hays, Ron D., Michelle E. Tarver, Karen L. Spritzer, et al.. (2016). Assessment of the Psychometric Properties of a Questionnaire Assessing Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL). JAMA Ophthalmology. 135(1). 3–3. 30 indexed citations
9.
Hilmantel, Gene, Michelle E. Tarver, Elizabeth M. Hofmeister, et al.. (2016). Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmology. 135(1). 13–13. 76 indexed citations
10.
Rosen, David L., Carol E. Golin, Catherine A. Grodensky, et al.. (2014). Opt-out HIV testing in prison: informed and voluntary?. AIDS Care. 27(5). 545–554. 19 indexed citations
11.
Winhusen, Theresa, Frankie Kropp, Robert Lindblad, et al.. (2014). Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence. The Journal of Clinical Psychiatry. 75(7). 757–764. 48 indexed citations
12.
Wohl, David A., Carol E. Golin, David L. Rosen, Jeanine May, & Becky L. White. (2013). Detection of Undiagnosed HIV Among State Prison Entrants. JAMA. 310(20). 2198–2198. 20 indexed citations
13.
Martin, Pauline L., et al.. (1996). Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 490–499. 29 indexed citations
14.
Belluzzi, J. D., E. F. Domino, Jeanine May, Krys S. Bankiewicz, & Donald A. McAfee. (1994). N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease. Movement Disorders. 9(2). 147–154. 57 indexed citations
16.
Barrett, Robert J., et al.. (1993). In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 265(1). 227–236. 10 indexed citations
17.
Fox, Anthony W., et al.. (1985). Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.. Journal of Pharmacology and Experimental Therapeutics. 235(3). 715–723. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026